Three years after the pandemic had destroyed any attempt to get back to the East Coast and Washington, DC, I was back in Avindra Nath’s office at the NIH’s huge Clinical Center. The world’s largest hospital that’s devoted entirely to clinical...
The big news in David Systrom’s “Neurovascular Dysregulation Underlies Exercise Intolerance in ME/CFS” talk at the CDC yesterday was that the $8 million mitochondrial drug trial had, unfortunately, failed. The ME/CFS Mitochondrial Drug Trial Fails...
How a coronavirus study shed light on Epstein-Barr Virus reactivation in ME/CFS. Of all the opportunities the SARS-CoV-2 virus has inadvertently opened up for chronic fatigue syndrome (ME/CFS), this one might be the most creative thus far. This study highlights the...
Maureen Hanson’s group at Cornel continues to pound out fascinating results. The latest one – a preprint, “Single-cell transcriptomics of the immune system in ME/CFS at baseline and following symptom provocation” – again demonstrates why...
Researchers find yet another way to potentially explain long COVID and perhaps other post-infectious illnesses One outcome of more or less abundant funding and the worldwide reach of COVID-19 is the creativity that gets unleashed. This Harvard study “Impact of...
It’s like a sapling putting out roots. Will it grow into a big tree or will it die on the vine? However, it turns out, Andreas Goebel Ph.D. has certainly planted some fascinating and possibly game-changing ideas about how fibromyalgia, ME/CFS, and long COVID...
